5 Drug Profile
5 Drug Profile
DRUG PROFILE
CLOPIDOGREL BISULPHATE
Clopidogrel is an antiplatelet medication used to reduce the risk of heart disease and stroke
in those at high risk. It is also used together with aspirin in heart attacks and following the
placement of a coronary artery stent (dual antiplatelet therapy). It is taken by mouth. Onset
of effects is about two hours and lasts for five days. It comes under BCS class 2.
Solubility-1] water-0.1183g/mol
2]The solubility of clopidogrel in alcohols is ranked as ethanol > propanol > butanol >
isopropanol
Absorption-
Metabolism-
Route of elimination-
An oral dose of radiolabeled clopidogrel is excreted 50% in the urine and 46%
in the feces over 5 days.9 The remainder of clopidogrel is irreversibly bound to
platelets for their lifetime, or approximately 8-11 days.
Adverse effects-
Headache, nausea, easy bruising, itching, and heartburn. More severe side
effects include bleeding and thrombotic thrombocytopenic purpura.
Contraindication-
Hypersensitivity to the drug or components of it.
Active pathologic bleeding such as intracranial bleeding or peptic ulcers.
CYP2C19 poor metabolizers.
EXCIPIENTS PROFILE
ETHYL CELLULOSE-
EUDRAGIT
Empirical Formula-(C2H4O)n
Melting point: 228⁰C for fully hydrolysed grades
180⁰C-190⁰C for partially hydrolysed grades
Refractive Index- nD25=1.49-1.53
Solubility-PVA is soluble in water and insoluble in organic.